New Jersey Medicaid and semaglutide
New Jersey Medicaid did not cover GLP-1s for weight loss as of January 2026, according to KFF, though it must cover them for type 2 diabetes.
In 2025 New Jersey Medicaid paid for 71,402 semaglutide prescriptions (Ozempic, Wegovy, Rybelsus), 43% of its GLP-1 prescriptions and 18th of the 50 states and DC. It reimbursed $71.3 million before rebates, $998 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 64,809 | $63.5 million | $979 |
| Wegovy | 3,829 | $5.1 million | $1,325 |
| Rybelsus | 2,764 | $2.7 million | $979 |
New Jersey plans and prescribing rules
New Jersey State Health Benefits Program (SHBP). New Jersey's State Health Benefits Program covers Wegovy, Saxenda and Zepbound for weight loss in 2026, at a $45 copay for a 30-day retail supply or $135 for a 90-day mail-order supply.
Semaglutide in the states around New Jersey
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| New Jersey | 19 | $39/moWellmedr | 71,402 | Medicaid Wegovy: Not covered (KFF) |
| Delaware | 19 | $39/moWellmedr | 36,313 | Medicaid Wegovy: Unclear |
| New York | 19 | $39/moWellmedr | 488,820 | Medicaid Wegovy: No |
| Pennsylvania | 19 | $39/moWellmedr | 485,068 | Medicaid Wegovy: No |



